{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:50:10Z","timestamp":1791078610749,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":253,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642451058","type":"print"},{"value":"9783642451065","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-642-45106-5_14","type":"book-chapter","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T11:59:37Z","timestamp":1395748777000},"page":"357-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Chiara","family":"Zuccato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,30]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.21139","volume":"85","author":"T Aid","year":"2007","unstructured":"Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85:525\u2013535","journal-title":"J Neurosci Res"},{"issue":"6148","key":"14_CR225","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","volume":"341","author":"A Aiuti","year":"2013","unstructured":"Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, Dionisio F, Calabria A, Giannelli S, Castiello MC, Bosticardo M, Evangelio C, Assanelli A, Casiraghi M, Di Nunzio S, Callegaro L, Benati C, Rizzardi P, Pellin D, Di Serio C, Schmidt M, Von Kalle C, Gardner J, Mehta N, Neduva V, Dow DJ, Galy A, Miniero R, Finocchi A, Metin A, Banerjee PP, Orange JS, Galimberti S, Valsecchi MG, Biffi A, Montini E, Villa A, Ciceri F, Roncarolo MG, Naldini L (2013) Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341(6148):1233151","journal-title":"Science"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/01.wnl.0000175977.57661.b1","volume":"65","author":"J Alberch","year":"2005","unstructured":"Alberch J, Lopez M, Badenas C, Carrasco JL, Mila M, Munoz E, Canals JM (2005) Association between BDNF Val66Met polymorphism and age at onset in Huntington disease. Neurology 65:964\u2013965","journal-title":"Neurology"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/10611860903318134","volume":"18","author":"SR Alcala-Barraza","year":"2010","unstructured":"Alcala-Barraza SR, Lee MS, Hanson LR, McDonald AA, Frey WH 2nd, McLoon LK (2010) Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target 18:179\u2013190","journal-title":"J Drug Target"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856\u2013860","journal-title":"Nature"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","volume":"39","author":"BL Apostol","year":"2008","unstructured":"Apostol BL, Simmons DA, Zuccato C, Illes K, Pallos J, Casale M, Conforti P, Ramos C, Roarke M, Kathuria S, Cattaneo E, Marsh JL, Thompson LM (2008) CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice. Mol Cell Neurosci 39:8\u201320","journal-title":"Mol Cell Neurosci"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1471-4159.2004.02839.x","volume":"92","author":"CD Bailey","year":"2005","unstructured":"Bailey CD, Johnson GV (2005) Tissue transglutaminase contributes to disease progression in the R6\/2 Huntington\u2019s disease mouse model via aggregate-independent mechanisms. J Neurochem 92:83\u201392","journal-title":"J Neurochem"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24:4250\u20134258","journal-title":"J Neurosci"},{"issue":"6","key":"14_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/dev.20546","volume":"54","author":"KG Bath","year":"2012","unstructured":"Bath KG, Akins MR, Lee FS (2012) BDNF control of adult SVZ neurogenesis. Dev Psychobiol 54(6):578\u2013589. doi:10.1002\/dev.20546","journal-title":"Dev Psychobiol"},{"key":"14_CR9","doi-asserted-by":"crossref","unstructured":"Beister A, Kraus P, Kuhn W, Dose M, Weindl A, Gerlach M (2004) The N-methyl-D-aspartate antagonist memantine retards progression of Huntington\u2019s disease. J Neural Transm Suppl (68):117\u201322","DOI":"10.1007\/978-3-7091-0579-5_14"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/10430349950016393","volume":"10","author":"AP Bemelmans","year":"1999","unstructured":"Bemelmans AP, Horellou P, Pradier L, Brunet I, Colin P, Mallet J (1999) Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington\u2019s disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 10:2987\u20132997","journal-title":"Hum Gene Ther"},{"key":"14_CR226","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1523\/JNEUROSCI.5110-12.2013","volume":"33","author":"K Ben M\u2019Barek","year":"2013","unstructured":"Ben M\u2019Barek K, Pla P, Orvoen S, Benstaali C, Godin JD, Gardier AM, Saudou F, David DJ, Humbert S (2013) Huntingtin mediates anxiety\/depression-related behaviors and hippocampal neurogenesis. J Neurosci 33:8608\u20138620","journal-title":"J Neurosci"},{"key":"14_CR253","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.stem.2013.04.014","volume":"12","author":"A Benraiss","year":"2013","unstructured":"Benraiss A, Toner MJ, Xu Q, Bruel-Jungerman E, Rogers EH, Wang F, Economides AN, Davidson BL, Kageyama R, Nedergaard M, Goldman SA (2013) Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington\u2019s disease. Cell Stem Cell 12:787\u2013799","journal-title":"Cell Stem Cell"},{"issue":"6148","key":"14_CR227","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, Baldoli C, Martino S, Calabria A, Canale S, Benedicenti F, Vallanti G, Biasco L, Leo S, Kabbara N, Zanetti G, Rizzo WB, Mehta NA, Cicalese MP, Casiraghi M, Boelens JJ, Del Carro U, Dow DJ, Schmidt M, Assanelli A, Neduva V, Di Serio C, Stupka E, Gardner J, von Kalle C, Bordignon C, Ciceri F, Rovelli A, Roncarolo MG, Aiuti A, Sessa M, Naldini L (2013) Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341(6148):1233158","journal-title":"Science"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1089\/hum.2005.16.1133","volume":"16","author":"A Biffi","year":"2005","unstructured":"Biffi A, Naldini L (2005) Gene therapy of storage disorders by retroviral and lentiviral vectors. Hum Gene Ther 16:1133\u20131142","journal-title":"Hum Gene Ther"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1097\/00001756-199707070-00031","volume":"8","author":"J Block-Galarza","year":"1997","unstructured":"Block-Galarza J, Chase KO, Sapp E, Vaughn KT, Vallee RB, DiFiglia M, Aronin N (1997) Fast transport and retrograde movement of huntingtin and HAP 1 in axons. Neuroreport 8:2247\u20132251","journal-title":"Neuroreport"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","volume":"116","author":"M Borrell-Pages","year":"2006","unstructured":"Borrell-Pages M, Canals JM, Cordelieres FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Neri C, Alberch J, Brouillet E, Saudou F, Humbert S (2006) Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest 116:1410\u20131424","journal-title":"J Clin Invest"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1471-4159.2010.06874.x","volume":"114","author":"M Bousquet","year":"2010","unstructured":"Bousquet M, Gibrat C, Ouellet M, Rouillard C, Calon F, Cicchetti F (2010) Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases. J Neurochem 114:1651\u20131658","journal-title":"J Neurochem"},{"key":"14_CR229","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/ana.410380629","volume":"38","author":"WG Bradley","year":"1995","unstructured":"Bradley WG, Miami FL, The BDNF Trial Group (1995) A PhaseI\/II study of recombinant human brain-derived neurotrophic factor in patients with amyotrophic lateral sclerosis. Ann Neurol 38:971","journal-title":"Ann Neurol"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"10458","DOI":"10.1073\/pnas.0401827101","volume":"101","author":"AW Bruce","year":"2004","unstructured":"Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, Chapman M, Gottgens B, Buckley NJ (2004) Genome-wide analysis of repressor element 1 silencing transcription factor\/neuron-restrictive silencing factor (REST\/NRSF) target genes. Proc Natl Acad Sci USA 101:10458\u201310463","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V","volume":"45","author":"AJ Bruce-Keller","year":"1999","unstructured":"Bruce-Keller AJ, Umberger G, McFall R, Mattson MP (1999) Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann Neurol 45:8\u201315","journal-title":"Ann Neurol"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"33791","DOI":"10.1074\/jbc.M204861200","volume":"277","author":"J Carmichael","year":"2002","unstructured":"Carmichael J, Sugars KL, Bao YP, Rubinsztein DC (2002) Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington\u2019s disease mutation. J Biol Chem 277:33791\u201333798","journal-title":"J Biol Chem"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S (2001) Loss of normal huntingtin function: new developments in Huntington\u2019s disease research. Trends Neurosci 24:182\u2013188","journal-title":"Trends Neurosci"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci 6:919\u2013930","journal-title":"Nat Rev Neurosci"},{"key":"14_CR230","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/stem.1430","volume":"31","author":"J Charbord","year":"2013","unstructured":"Charbord J, Poydenot P, Bonnefond C, Feyeux M, Casagrande F, Brinon B, Francelle L, Aur\u00e9gan G, Guillermier M, Cailleret M, Viegas P, Nicoleau C, Martinat C, Brouillet E, Cattaneo E, Peschanski M, Lechuga M, Perrier AL (2013) High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes. Stem Cells 31:1816\u20131828","journal-title":"Stem Cells"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"DT Chang","year":"2006","unstructured":"Chang DT, Rintoul GL, Pandipati S, Reynolds IJ (2006) Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 22:388\u2013400","journal-title":"Neurobiol Dis"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2003-38093","volume":"36","author":"S Chari","year":"2003","unstructured":"Chari S, Quraishi SH, Jainer AK (2003) Fluoxetine-induced exacerbation of chorea in Huntington\u2019s disease? A case report. Pharmacopsychiatry 36:41\u201343","journal-title":"Pharmacopsychiatry"},{"issue":"Pt 1","key":"14_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/bj3190103","volume":"319","author":"ME Cheetham","year":"1996","unstructured":"Cheetham ME, Anderton BH, Jackson AP (1996) Inhibition of hsc70-catalysed clathrin uncoating by HSJ1 proteins. Biochem J 319(Pt 1):103\u2013108","journal-title":"Biochem J"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1523\/JNEUROSCI.23-07-02572.2003","volume":"23","author":"WG Chen","year":"2003","unstructured":"Chen WG, West AE, Tao X, Corfas G, Szentirmay MN, Sawadogo M, Vinson C, Greenberg ME (2003a) Upstream stimulatory factors are mediators of Ca2+\u2212responsive transcription in neurons. J Neurosci 23:2572\u20132581","journal-title":"J Neurosci"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1126\/science.1086446","volume":"302","author":"WG Chen","year":"2003","unstructured":"Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME (2003b) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885\u2013889","journal-title":"Science"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1523\/JNEUROSCI.0348-04.2004","volume":"24","author":"ZY Chen","year":"2004","unstructured":"Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, Lee FS (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24:4401\u20134411","journal-title":"J Neurosci"},{"key":"14_CR231","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","volume":"36","author":"CT Chiu","year":"2011","unstructured":"Chiu CT, Liu G, Leeds P, Chuang DM (2011) Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington\u2019s disease. Neuropsychopharmacology 36:2406\u20132421","journal-title":"Neuropsychopharmacology"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1172\/JCI31778","volume":"117","author":"SR Cho","year":"2007","unstructured":"Cho SR, Benraiss A, Chmielnicki E, Samdani A, Economides A, Goldman SA (2007) Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease. J Clin Invest 117:2889\u20132902","journal-title":"J Clin Invest"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","volume":"144B","author":"A Ciammola","year":"2007","unstructured":"Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, Frati L, Squitieri F, Silani V (2007) Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington\u2019s disease patients. Am J Med Genet B Neuropsychiatr Genet 144B:574\u2013577","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/emboj.2008.133","volume":"27","author":"E Colin","year":"2008","unstructured":"Colin E, Zala D, Liot G, Rangone H, Borrell-Pages M, Li XJ, Saudou F, Humbert S (2008) Huntingtin phosphorylation acts as a molecular switch for anterograde\/retrograde transport in neurons. EMBO J 27:2124\u20132134","journal-title":"EMBO J"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.870120319","volume":"12","author":"PG Como","year":"1997","unstructured":"Como PG, Rubin AJ, O\u2019Brien CF, Lawler K, Hickey C, Rubin AE, Henderson R, McDermott MP, McDermott M, Steinberg K, Shoulson I (1997) A controlled trial of fluoxetine in nondepressed patients with Huntington\u2019s disease. Mov Disord 12:397\u2013401","journal-title":"Mov Disord"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2008.04.012","volume":"39","author":"P Conforti","year":"2008","unstructured":"Conforti P, Ramos C, Apostol BL, Simmons DA, Nguyen HP, Riess O, Thompson LM, Zuccato C, Cattaneo E (2008) Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington\u2019s disease: restoration by the neuroprotective compound CEP-1347. Mol Cell Neurosci 39:1\u20137","journal-title":"Mol Cell Neurosci"},{"key":"14_CR232","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/gt.2012.84","volume":"20","author":"P Conforti","year":"2012","unstructured":"Conforti P, Mas Monteys A, Zuccato C, Buckley NJ, Davidson B, Cattaneo E (2012) In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice. Gene Ther 20:678\u2013685","journal-title":"Gene Ther"},{"key":"14_CR233","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jnc.12348","volume":"127","author":"P Conforti","year":"2013","unstructured":"Conforti P, Zuccato C, Gaudenzi G, Ieraci A, Camnasio S, Buckley NJ, Mutti C, Cotelli F, Contini A, Cattaneo E (2013) Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington\u2019s disease models. J Neurochem 127:22\u201335","journal-title":"J Neurochem"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nrn2761","volume":"11","author":"L Conti","year":"2010","unstructured":"Conti L, Cattaneo E (2010) Neural stem cell systems: physiological players or in vitro entities? Nat Rev Neurosci 11:176\u2013187","journal-title":"Nat Rev Neurosci"},{"key":"14_CR33","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0306-4522(99)00296-1","volume":"93","author":"SD Croll","year":"1999","unstructured":"Croll SD, Suri C, Compton DL, Simmons MV, Yancopoulos GD, Lindsay RM, Wiegand SJ, Rudge JS, Scharfman HE (1999) Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 93:1491\u20131506","journal-title":"Neuroscience"},{"key":"14_CR234","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1152\/jn.00762.2011","volume":"107","author":"DM Cummings","year":"2012","unstructured":"Cummings DM, Alaghband Y, Hickey MA, Joshi PR, Hong SC, Zhu C, Ando TK, Andr\u00e9 VM, Cepeda C, Watson JB, Levine MS (2012) A critical window of CAG repeat-length correlates with phenotype severity in the R6\/2 mouse model of Huntington\u2019s disease. J Neurophysiol 107:677\u2013691","journal-title":"J Neurophysiol"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/bbrc.1999.0851","volume":"260","author":"T de Cristofaro","year":"1999","unstructured":"de Cristofaro T, Affaitati A, Cariello L, Avvedimento EV, Varrone S (1999) The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates. Biochem Biophys Res Commun 260:150\u2013158","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","volume":"22","author":"A Dedeoglu","year":"2002","unstructured":"Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJ, Ratan RR, Beal MF, Hersch SM, Ferrante RJ (2002) Therapeutic effects of cystamine in a murine model of Huntington\u2019s disease. J Neurosci 22:8942\u20138950","journal-title":"J Neurosci"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.1523\/JNEUROSCI.3873-06.2006","volume":"26","author":"D del Toro","year":"2006","unstructured":"del Toro D, Canals JM, Gines S, Kojima M, Egea G, Alberch J (2006) Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. J Neurosci 26:12748\u201312757","journal-title":"J Neurosci"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nbd.2006.07.002","volume":"24","author":"E Di Maria","year":"2006","unstructured":"Di Maria E, Marasco A, Tartari M, Ciotti P, Abbruzzese G, Novelli G, Bellone E, Cattaneo E, Mandich P (2006) No evidence of association between BDNF gene variants and age-at-onset of Huntington\u2019s disease. Neurobiol Dis 24:274\u2013279","journal-title":"Neurobiol Dis"},{"key":"14_CR38","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.6039-08.2009","volume":"29","author":"H Diekmann","year":"2009","unstructured":"Diekmann H, Anichtchik O, Fleming A, Futter M, Goldsmith P, Roach A, Rubinsztein DC (2009) Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. J Neurosci 29:1343\u20131349","journal-title":"J Neurosci"},{"key":"14_CR39","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M DiFiglia","year":"1995","unstructured":"DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel JP, Carraway R, Reeves SA et al (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075\u20131081","journal-title":"Neuron"},{"key":"14_CR40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","volume":"26","author":"I Dragatsis","year":"2000","unstructured":"Dragatsis I, Levine MS, Zeitlin S (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet 26:300\u2013306","journal-title":"Nat Genet"},{"key":"14_CR254","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nbd.2008.10.009","volume":"33","author":"I Dragatsis","year":"2009","unstructured":"Dragatsis I, Goldowitz D, Del Mar N, Deng YP, Meade CA, Liu L, Sun Z, Dietrich P, Yue J, Reiner A (2009) CAG repeat lengths > or =335 attenuate the phenotype in the R6\/2 Huntington\u2019s disease transgenic mouse. Neurobiol Dis 33:315\u2013330","journal-title":"Neurobiol Dis"},{"key":"14_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JMN:16:1:1","volume":"16","author":"W Duan","year":"2001","unstructured":"Duan W, Lee J, Guo Z, Mattson MP (2001a) Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury. J Mol Neurosci 16:1\u201312","journal-title":"J Mol Neurosci"},{"key":"14_CR42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1471-4159.2001.00071.x","volume":"76","author":"W Duan","year":"2001","unstructured":"Duan W, Guo Z, Mattson MP (2001b) Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J Neurochem 76:619\u2013626","journal-title":"J Neurochem"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","volume":"100","author":"W Duan","year":"2003","unstructured":"Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 100:2911\u20132916","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR44","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.20075","volume":"55","author":"W Duan","year":"2004","unstructured":"Duan W, Guo Z, Jiang H, Ladenheim B, Xu X, Cadet JL, Mattson MP (2004) Paroxetine retards disease onset and progression in Huntingtin mutant mice. Ann Neurol 55:590\u2013594","journal-title":"Ann Neurol"},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","volume":"30","author":"W Duan","year":"2008","unstructured":"Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, Ladenheim B, Zhao M, Cadet JL, Wong J, Ross CA (2008) Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington\u2019s disease. Neurobiol Dis 30:312\u2013322","journal-title":"Neurobiol Dis"},{"key":"14_CR46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/abbi.1996.0380","volume":"333","author":"A Dubey","year":"1996","unstructured":"Dubey A, Forster MJ, Lal H, Sohal RS (1996) Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch Biochem Biophys 333:189\u2013197","journal-title":"Arch Biochem Biophys"},{"key":"14_CR47","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, Mouradian MM, Young AB, Tanese N, Krainc D (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease. Science 296:2238\u20132243","journal-title":"Science"},{"key":"14_CR48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","volume":"112","author":"MF Egan","year":"2003","unstructured":"Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257\u2013269","journal-title":"Cell"},{"key":"14_CR49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/386395a0","volume":"386","author":"DF Emerich","year":"1997","unstructured":"Emerich DF, Winn SR, Hantraye PM, Peschanski M, Chen EY, Chu Y, McDermott P, Baetge EE, Kordower JH (1997) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington\u2019s disease. Nature 386:395\u2013399","journal-title":"Nature"},{"key":"14_CR50","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/6.13.2205","volume":"6","author":"S Engelender","year":"1997","unstructured":"Engelender S, Sharp AH, Colomer V, Tokito MK, Lanahan A, Worley P, Holzbaur EL, Ross CA (1997) Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum Mol Genet 6:2205\u20132212","journal-title":"Hum Mol Genet"},{"key":"14_CR51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0304-3940(92)90494-R","volume":"138","author":"T Falkenberg","year":"1992","unstructured":"Falkenberg T, Mohammed AK, Henriksson B, Persson H, Winblad B, Lindefors N (1992) Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett 138:153\u2013156","journal-title":"Neurosci Lett"},{"key":"14_CR52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866:257\u2013261","journal-title":"Brain Res"},{"key":"14_CR53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1471-4159.2004.02726.x","volume":"91","author":"JH Fox","year":"2004","unstructured":"Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, Buzescu R, Chopra R, Ferrante RJ, Kazantsev A, Hersch SM (2004) Cystamine increases L-cysteine levels in Huntington\u2019s disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. J Neurochem 91:413\u2013422","journal-title":"J Neurochem"},{"key":"14_CR54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00001756-199304000-00006","volume":"4","author":"DM Frim","year":"1993","unstructured":"Frim DM, Uhler TA, Short MP, Ezzedine ZD, Klagsbrun M, Breakefield XO, Isacson O (1993) Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. Neuroreport 4:367\u2013370","journal-title":"Neuroreport"},{"key":"14_CR55","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0037-1613072","volume":"87","author":"H Fujimura","year":"2002","unstructured":"Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J, Sun B, Tandon NN (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87:728\u2013734","journal-title":"Thromb Haemost"},{"key":"14_CR56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002130100871","volume":"158","author":"T Fukumoto","year":"2001","unstructured":"Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158:100\u2013106","journal-title":"Psychopharmacology (Berl)"},{"key":"14_CR57","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","volume":"19","author":"FR Fusco","year":"1999","unstructured":"Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington\u2019s disease. J Neurosci 19:1189\u20131202","journal-title":"J Neurosci"},{"key":"14_CR58","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","volume":"18","author":"FR Fusco","year":"2003","unstructured":"Fusco FR, Zuccato C, Tartari M, Martorana A, De March Z, Giampa C, Cattaneo E, Bernardi G (2003) Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. Eur J Neurosci 18:1093\u20131102","journal-title":"Eur J Neurosci"},{"key":"14_CR235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","volume":"37","author":"R Gabathuler","year":"2010","unstructured":"Gabathuler R (2010) Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 37:48\u201357","journal-title":"Neurobiol Dis"},{"key":"14_CR59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"14_CR60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1568007043482552","volume":"3","author":"V Gentile","year":"2004","unstructured":"Gentile V, Cooper AJ (2004) Transglutaminases \u2013 possible drug targets in human diseases. Curr Drug Targets CNS Neurol Disord 3:99\u2013104","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"14_CR236","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/pharmaceutics5010127","volume":"5","author":"C G\u00e9ral","year":"2013","unstructured":"G\u00e9ral C, Angelova A, Lesieur S (2013) From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics 5:127\u2013167","journal-title":"Pharmaceutics"},{"key":"14_CR61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","volume":"105","author":"K Gharami","year":"2008","unstructured":"Gharami K, Xie Y, An JJ, Tonegawa S, Xu B (2008) Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington\u2019s disease phenotypes in mice. J Neurochem 105:369\u2013379","journal-title":"J Neurochem"},{"key":"14_CR62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1460-9568.2005.04545.x","volume":"23","author":"C Giampa","year":"2006","unstructured":"Giampa C, DeMarch Z, D\u2019Angelo V, Morello M, Martorana A, Sancesario G, Bernardi G, Fusco FR (2006) Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington\u2019s disease. Eur J Neurosci 23:11\u201320","journal-title":"Eur J Neurosci"},{"issue":"5","key":"14_CR237","doi-asserted-by":"crossref","first-page":"e64037","DOI":"10.1371\/journal.pone.0064037","volume":"8","author":"C Giamp\u00e0","year":"2013","unstructured":"Giamp\u00e0 C, Montagna E, Dato C, Melone MA, Bernardi G, Fusco FR (2013) Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington\u2019s disease. PLoS One 8(5):e64037","journal-title":"PLoS One"},{"key":"14_CR63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pnpbp.2010.11.023","volume":"35","author":"C Gibrat","year":"2011","unstructured":"Gibrat C, Cicchetti F (2011) Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry 35:380\u2013389","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"14_CR64","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","volume":"20","author":"JM Gil","year":"2005","unstructured":"Gil JM, Mohapel P, Araujo IM, Popovic N, Li JY, Brundin P, Petersen A (2005) Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington\u2019s disease mice. Neurobiol Dis 20:744\u2013751","journal-title":"Neurobiol Dis"},{"key":"14_CR65","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","volume":"9","author":"SS Gill","year":"2003","unstructured":"Gill SS, Patel NK, Hotton GR, O\u2019Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589\u2013595","journal-title":"Nat Med"},{"key":"14_CR66","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","volume":"12","author":"S Gines","year":"2003","unstructured":"Gines S, Seong IS, Fossale E, Ivanova E, Trettel F, Gusella JF, Wheeler VC, Persichetti F, MacDonald ME (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice. Hum Mol Genet 12:497\u2013508","journal-title":"Hum Mol Genet"},{"key":"14_CR67","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","volume":"23","author":"S Gines","year":"2006","unstructured":"Gines S, Bosch M, Marco S, Gavalda N, Diaz-Hernandez M, Lucas JJ, Canals JM, Alberch J (2006) Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain. Eur J Neurosci 23:649\u2013658","journal-title":"Eur J Neurosci"},{"key":"14_CR238","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","volume":"6","author":"A Giralt","year":"2011","unstructured":"Giralt A, Carret\u00f3n O, Lao-Peregrin C, Mart\u00edn ED, Alberch J (2011) Conditional BDNF release under pathological conditions improves Huntington\u2019s disease pathology by delaying neuronal dysfunction. Mol Neurodegener 6:71","journal-title":"Mol Neurodegener"},{"key":"14_CR68","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","volume":"158","author":"A Giralt","year":"2009","unstructured":"Giralt A, Rodrigo T, Martin ED, Gonzalez JR, Mila M, Cena V, Dierssen M, Canals JM, Alberch J (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience 158:1234\u20131250","journal-title":"Neuroscience"},{"key":"14_CR69","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/gt.2010.71","volume":"17","author":"A Giralt","year":"2010","unstructured":"Giralt A, Friedman HC, Caneda-Ferron B, Urban N, Moreno E, Rubio N, Blanco J, Peterson A, Canals JM, Alberch J (2010) BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington\u2019s disease. Gene Ther 17:1294\u20131308","journal-title":"Gene Ther"},{"key":"14_CR70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1398-9219.2004.00182.x","volume":"5","author":"PA Gleeson","year":"2004","unstructured":"Gleeson PA, Lock JG, Luke MR, Stow JL (2004) Domains of the TGN: coats, tethers and G proteins. Traffic 5:315\u2013326","journal-title":"Traffic"},{"key":"14_CR71","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182\u20136195","journal-title":"J Neurosci"},{"key":"14_CR72","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","volume":"22","author":"HE Grote","year":"2005","unstructured":"Grote HE, Bull ND, Howard ML, van Dellen A, Blakemore C, Bartlett PF, Hannan AJ (2005) Cognitive disorders and neurogenesis deficits in Huntington\u2019s disease mice are rescued by fluoxetine. Eur J Neurosci 22:2081\u20132088","journal-title":"Eur J Neurosci"},{"key":"14_CR73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archneur.62.1.46","volume":"62","author":"S Gunawardena","year":"2005","unstructured":"Gunawardena S, Goldstein LS (2005) Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways. Arch Neurol 62:46\u201351","journal-title":"Arch Neurol"},{"key":"14_CR74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","volume":"40","author":"S Gunawardena","year":"2003","unstructured":"Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, Gordesky-Gold B, Sintasath L, Bonini NM, Goldstein LS (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40:25\u201340","journal-title":"Neuron"},{"key":"14_CR75","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1471-4159.2000.0750314.x","volume":"75","author":"Z Guo","year":"2000","unstructured":"Guo Z, Ersoz A, Butterfield DA, Mattson MP (2000) Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid. J Neurochem 75:314\u2013320","journal-title":"J Neurochem"},{"key":"14_CR76","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","volume":"118","author":"S Hacein-Bey-Abina","year":"2008","unstructured":"Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, Asnafi V, MacIntyre E, Dal Cortivo L, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118:3132\u20133142","journal-title":"J Clin Invest"},{"key":"14_CR77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2826.2005.01390.x","volume":"18","author":"AC Hansson","year":"2006","unstructured":"Hansson AC, Sommer WH, Metsis M, Stromberg I, Agnati LF, Fuxe K (2006) Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter. J Neuroendocrinol 18:104\u2013114","journal-title":"J Neuroendocrinol"},{"key":"14_CR78","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2009.05.007","volume":"384","author":"D Hara","year":"2009","unstructured":"Hara D, Fukuchi M, Miyashita T, Tabuchi A, Takasaki I, Naruse Y, Mori N, Kondo T, Tsuda M (2009) Remote control of activity-dependent BDNF gene promoter-I transcription mediated by REST\/NRSF. Biochem Biophys Res Commun 384:506\u2013511","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR79","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1523\/JNEUROSCI.23-17-06690.2003","volume":"23","author":"AR Hariri","year":"2003","unstructured":"Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23:6690\u20136694","journal-title":"J Neurosci"},{"key":"14_CR80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","volume":"41","author":"T Hathorn","year":"2011","unstructured":"Hathorn T, Snyder-Keller A, Messer A (2011) Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington\u2019s disease. Neurobiol Dis 41:43\u201350","journal-title":"Neurobiol Dis"},{"key":"14_CR81","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"HDCRG","year":"1993","unstructured":"HDCRG (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"14_CR82","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1093\/hmg\/ddp455","volume":"18","author":"TL Henshall","year":"2009","unstructured":"Henshall TL, Tucker B, Lumsden AL, Nornes S, Lardelli MT, Richards RI (2009) Selective neuronal requirement for huntingtin in the developing zebrafish. Hum Mol Genet 18:4830\u20134842","journal-title":"Hum Mol Genet"},{"key":"14_CR83","doi-asserted-by":"crossref","first-page":"13662","DOI":"10.1523\/JNEUROSCI.4144-08.2008","volume":"28","author":"LS Her","year":"2008","unstructured":"Her LS, Goldstein LS (2008) Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin. J Neurosci 28:13662\u201313672","journal-title":"J Neurosci"},{"key":"14_CR84","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","volume":"11","author":"E Hermel","year":"2004","unstructured":"Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE, Hackam AS, Logvinova AV, Peel AL, Chen SF, Hook V, Singaraja R, Krajewski S, Goldsmith PC, Ellerby HM, Hayden MR, Bredesen DE, Ellerby LM (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington\u2019s disease. Cell Death Differ 11:424\u2013438","journal-title":"Cell Death Differ"},{"issue":"Suppl 1","key":"14_CR85","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2184.2008.00486.x","volume":"41","author":"DC Hess","year":"2008","unstructured":"Hess DC, Borlongan CV (2008) Stem cells and neurological diseases. Cell Prolif 41(Suppl 1):94\u2013114","journal-title":"Cell Prolif"},{"key":"14_CR86","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","volume":"51","author":"E Hockly","year":"2002","unstructured":"Hockly E, Cordery PM, Woodman B, Mahal A, van Dellen A, Blakemore C, Lewis CM, Hannan AJ, Bates GP (2002) Environmental enrichment slows disease progression in R6\/2 Huntington\u2019s disease mice. Ann Neurol 51:235\u2013242","journal-title":"Ann Neurol"},{"key":"14_CR87","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, Hollingsworth ZR, Collin F, Synek B, Holmans PA, Young AB, Wexler NS, Delorenzi M, Kooperberg C, Augood SJ, Faull RL, Olson JM, Jones L, Luthi-Carter R (2006) Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet 15:965\u2013977","journal-title":"Hum Mol Genet"},{"key":"14_CR88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"14_CR89","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.2741\/1764","volume":"10","author":"G Hoffner","year":"2005","unstructured":"Hoffner G, Djian P (2005) Transglutaminase and diseases of the central nervous system. Front Biosci 10:3078\u20133092","journal-title":"Front Biosci"},{"key":"14_CR90","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/01.WNL.0000096019.71649.2B","volume":"61","author":"HSG","year":"2003","unstructured":"HSG (2003) Dosage effects of riluzole in Huntington\u2019s disease: a multicenter placebo-controlled study. Neurology 61:1551\u20131556","journal-title":"Neurology"},{"key":"14_CR91","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jnr.10702","volume":"74","author":"R Ientile","year":"2003","unstructured":"Ientile R, Campisi A, Raciti G, Caccamo D, Curro M, Cannavo G, Li Volti G, Macaione S, Vanella A (2003) Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells. J Neurosci Res 74:52\u201359","journal-title":"J Neurosci Res"},{"key":"14_CR92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0298-111","volume":"18","author":"S Igarashi","year":"1998","unstructured":"Igarashi S, Koide R, Shimohata T, Yamada M, Hayashi Y, Takano H, Date H, Oyake M, Sato T, Sato A, Egawa S, Ikeuchi T, Tanaka H, Nakano R, Tanaka K, Hozumi I, Inuzuka T, Takahashi H, Tsuji S (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet 18:111\u2013117","journal-title":"Nat Genet"},{"key":"14_CR93","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1523\/JNEUROSCI.19-13-05409.1999","volume":"19","author":"S Ivkovic","year":"1999","unstructured":"Ivkovic S, Ehrlich ME (1999) Expression of the striatal DARPP-32\/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 19:5409\u20135419","journal-title":"J Neurosci"},{"key":"14_CR94","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroscience.2010.10.054","volume":"172","author":"Y Jiang","year":"2011","unstructured":"Jiang Y, Wei N, Lu T, Zhu J, Xu G, Liu X (2011) Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience 172:398\u2013405","journal-title":"Neuroscience"},{"key":"14_CR95","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","volume":"11","author":"R Johnson","year":"2009","unstructured":"Johnson R, Buckley NJ (2009) Gene dysregulation in Huntington\u2019s disease: REST, microRNAs and beyond. Neuromolecular Med 11:183\u2013199","journal-title":"Neuromolecular Med"},{"key":"14_CR96","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ (2008) A microRNA-based gene dysregulation pathway in Huntington\u2019s disease. Neurobiol Dis 29:438\u2013445","journal-title":"Neurobiol Dis"},{"key":"14_CR97","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/rme.10.72","volume":"5","author":"N Joyce","year":"2010","unstructured":"Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA (2010) Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 5:933\u2013946","journal-title":"Regen Med"},{"key":"14_CR98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","volume":"8","author":"MV Karpuj","year":"2002","unstructured":"Karpuj MV, Becher MW, Springer JE, Chabas D, Youssef S, Pedotti R, Mitchell D, Steinman L (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med 8:143\u2013149","journal-title":"Nat Med"},{"key":"14_CR99","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1096\/fj.02-0143fje","volume":"16","author":"R Katoh-Semba","year":"2002","unstructured":"Katoh-Semba R, Asano T, Ueda H, Morishita R, Takeuchi IK, Inaguma Y, Kato K (2002) Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J 16:1328\u20131330","journal-title":"FASEB J"},{"key":"14_CR100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","volume":"9","author":"AP Kells","year":"2004","unstructured":"Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B (2004) AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther 9:682\u2013688","journal-title":"Mol Ther"},{"key":"14_CR101","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/gt.2008.23","volume":"15","author":"AP Kells","year":"2008","unstructured":"Kells AP, Henry RA, Connor B (2008) AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment. Gene Ther 15:966\u2013977","journal-title":"Gene Ther"},{"key":"14_CR102","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/jnen\/63.6.598","volume":"63","author":"K Keyvani","year":"2004","unstructured":"Keyvani K, Sachser N, Witte OW, Paulus W (2004) Gene expression profiling in the intact and injured brain following environmental enrichment. J Neuropathol Exp Neurol 63:598\u2013609","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR103","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2006.07.008","volume":"24","author":"S Kishikawa","year":"2006","unstructured":"Kishikawa S, Li JL, Gillis T, Hakky MM, Warby S, Hayden M, MacDonald ME, Myers RH, Gusella JF (2006) Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington\u2019s disease. Neurobiol Dis 24:280\u2013285","journal-title":"Neurobiol Dis"},{"key":"14_CR104","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145710000738","volume":"14","author":"AB Klein","year":"2011","unstructured":"Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, Knudsen GM, Aznar S (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 14:347\u2013353","journal-title":"Int J Neuropsychopharmacol"},{"key":"14_CR105","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1210\/endo.140.9.6997","volume":"140","author":"N Koibuchi","year":"1999","unstructured":"Koibuchi N, Fukuda H, Chin WW (1999) Promoter-specific regulation of the brain-derived neurotropic factor gene by thyroid hormone in the developing rat cerebellum. Endocrinology 140:3955\u20133961","journal-title":"Endocrinology"},{"key":"14_CR106","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ana.21181","volume":"62","author":"GB Landwehrmeyer","year":"2007","unstructured":"Landwehrmeyer GB, Dubois B, de Yebenes JG, Kremer B, Gaus W, Kraus PH, Przuntek H, Dib M, Doble A, Fischer W, Ludolph AC (2007) Riluzole in Huntington\u2019s disease: a 3-year, randomized controlled study. Ann Neurol 62:262\u2013272","journal-title":"Ann Neurol"},{"key":"14_CR107","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","volume":"15","author":"SE Lazic","year":"2004","unstructured":"Lazic SE, Grote H, Armstrong RJ, Blakemore C, Hannan AJ, van Dellen A, Barker RA (2004) Decreased hippocampal cell proliferation in R6\/1 Huntington\u2019s mice. Neuroreport 15:811\u2013813","journal-title":"Neuroreport"},{"key":"14_CR108","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.0022-3042.2001.00747.x","volume":"80","author":"J Lee","year":"2002","unstructured":"Lee J, Seroogy KB, Mattson MP (2002) Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J Neurochem 80:539\u2013547","journal-title":"J Neurochem"},{"key":"14_CR109","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1016\/j.bmc.2008.03.067","volume":"16","author":"S Leone","year":"2008","unstructured":"Leone S, Mutti C, Kazantsev A, Sturlese M, Moro S, Cattaneo E, Rigamonti D, Contini A (2008) SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington\u2019s disease. Bioorg Med Chem 16:5695\u20135703","journal-title":"Bioorg Med Chem"},{"key":"14_CR110","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1074\/jbc.M205812200","volume":"278","author":"M Lesort","year":"2003","unstructured":"Lesort M, Lee M, Tucholski J, Johnson GV (2003) Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J Biol Chem 278:3825\u20133830","journal-title":"J Biol Chem"},{"key":"14_CR111","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/378398a0","volume":"378","author":"XJ Li","year":"1995","unstructured":"Li XJ, Li SH, Sharp AH, Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398\u2013402","journal-title":"Nature"},{"key":"14_CR112","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1523\/JNEUROSCI.18-04-01261.1998","volume":"18","author":"SH Li","year":"1998","unstructured":"Li SH, Gutekunst CA, Hersch SM, Li XJ (1998) Interaction of huntingtin-associated protein with dynactin P150Glued. J Neurosci 18:1261\u20131269","journal-title":"J Neurosci"},{"key":"14_CR113","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","volume":"22","author":"SH Li","year":"2002","unstructured":"Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22:1277\u20131287","journal-title":"Mol Cell Biol"},{"key":"14_CR239","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1523\/JNEUROSCI.2033-12.2013","volume":"33","author":"G Liot","year":"2013","unstructured":"Liot G, Zala D, Pla P, Mottet G, Piel M, Saudou F (2013) Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J Neurosci 33:6298\u20136309","journal-title":"J Neurosci"},{"key":"14_CR114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2005.10.004","volume":"1067","author":"QR Liu","year":"2006","unstructured":"Liu QR, Lu L, Zhu XG, Gong JP, Shaham Y, Uhl GR (2006) Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res 1067:1\u201312","journal-title":"Brain Res"},{"key":"14_CR115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/156720507783018316","volume":"4","author":"FM Longo","year":"2007","unstructured":"Longo FM, Yang T, Knowles JK, Xie Y, Moore LA, Massa SM (2007) Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer\u2019s disease mechanisms. Curr Alzheimer Res 4:503\u2013506","journal-title":"Curr Alzheimer Res"},{"key":"14_CR116","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","volume":"11","author":"R Luthi-Carter","year":"2002","unstructured":"Luthi-Carter R, Hanson SA, Strand AD, Bergstrom DA, Chun W, Peters NL, Woods AM, Chan EY, Kooperberg C, Krainc D, Young AB, Tapscott SJ, Olson JM (2002) Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum Mol Genet 11:1911\u20131926","journal-title":"Hum Mol Genet"},{"key":"14_CR117","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch G, Kramar EA, Rex CS, Jia Y, Chappas D, Gall CM, Simmons DA (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington\u2019s disease. J Neurosci 27:4424\u20134434","journal-title":"J Neurosci"},{"key":"14_CR240","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1523\/JNEUROSCI.0534-12.2012","volume":"32","author":"MR Lyons","year":"2012","unstructured":"Lyons MR, Schwarz CM, West AE (2012) Members of the myocyte enhancer factor 2 transcription factor family differentially regulate Bdnf transcription in response to neuronal depolarization. J Neurosci 32:12780\u201312785","journal-title":"J Neurosci"},{"key":"14_CR118","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2350-7-79","volume":"7","author":"M Mai","year":"2006","unstructured":"Mai M, Akkad AD, Wieczorek S, Saft C, Andrich J, Kraus PH, Epplen JT, Arning L (2006) No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. BMC Med Genet 7:79","journal-title":"BMC Med Genet"},{"key":"14_CR119","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"14_CR120","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1523\/JNEUROSCI.16-15-04604.1996","volume":"16","author":"A Martinez-Serrano","year":"1996","unstructured":"Martinez-Serrano A, Bjorklund A (1996) Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 16:4604\u20134616","journal-title":"J Neurosci"},{"key":"14_CR121","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1090842","volume":"302","author":"K Martinowich","year":"2003","unstructured":"Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302:890\u2013893","journal-title":"Science"},{"key":"14_CR122","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1186\/gb-2010-11-1-r9","volume":"11","author":"M Marullo","year":"2010","unstructured":"Marullo M, Zuccato C, Mariotti C, Lahiri N, Tabrizi SJ, Di Donato S, Cattaneo E (2010) Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data. Genome Biol 11:R9","journal-title":"Genome Biol"},{"key":"14_CR123","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/mcne.2001.1027","volume":"18","author":"M Marvanova","year":"2001","unstructured":"Marvanova M, Lakso M, Pirhonen J, Nawa H, Wong G, Castren E (2001) The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 18:247\u2013258","journal-title":"Mol Cell Neurosci"},{"key":"14_CR124","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI41356","volume":"120","author":"SM Massa","year":"2010","unstructured":"Massa SM, Yang T, Xie Y, Shi J, Bilgen M, Joyce JN, Nehama D, Rajadas J, Longo FM (2010) Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 120:1774\u20131785","journal-title":"J Clin Invest"},{"key":"14_CR125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1471-4159.2003.01586.x","volume":"84","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Duan W, Guo Z (2003) Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J Neurochem 84:417\u2013431","journal-title":"J Neurochem"},{"key":"14_CR126","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","volume":"9","author":"A McCampbell","year":"2000","unstructured":"McCampbell A, Taylor JP, Taye AA, Robitschek J, Li M, Walcott J, Merry D, Chai Y, Paulson H, Sobue G, Fischbeck KH (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9:2197\u20132202","journal-title":"Hum Mol Genet"},{"key":"14_CR127","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1074\/jbc.M509806200","volume":"281","author":"JR McGuire","year":"2006","unstructured":"McGuire JR, Rong J, Li SH, Li XJ (2006) Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem 281:3552\u20133559","journal-title":"J Biol Chem"},{"key":"14_CR128","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1073\/pnas.90.19.8802","volume":"90","author":"M Metsis","year":"1993","unstructured":"Metsis M, Timmusk T, Arenas E, Persson H (1993) Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc Natl Acad Sci USA 90:8802\u20138806","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00439-006-0221-2","volume":"120","author":"S Metzger","year":"2006","unstructured":"Metzger S, Bauer P, Tomiuk J, Laccone F, Didonato S, Gellera C, Mariotti C, Lange HW, Weirich-Schwaiger H, Wenning GK, Seppi K, Melegh B, Havasi V, Baliko L, Wieczorek S, Zaremba J, Hoffman-Zacharska D, Sulek A, Basak AN, Soydan E, Zidovska J, Kebrdlova V, Pandolfo M, Ribai P, Kadasi L, Kvasnicova M, Weber BH, Kreuz F, Dose M, Stuhrmann M, Riess O (2006) Genetic analysis of candidate genes modifying the age-at-onset in Huntington\u2019s disease. Hum Genet 120:285\u2013292","journal-title":"Hum Genet"},{"issue":"11","key":"14_CR241","doi-asserted-by":"crossref","first-page":"e27746","DOI":"10.1371\/journal.pone.0027746","volume":"6","author":"M Mielcarek","year":"2011","unstructured":"Mielcarek M, Benn CL, Franklin SA, Smith DL, Woodman B, Marks PA, Bates GP (2011) SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington\u2019s disease. PLoS One 6(11):e27746","journal-title":"PLoS One"},{"key":"14_CR242","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","volume":"65","author":"AJ Milnerwood","year":"2010","unstructured":"Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RW, Vasuta OC, Graham RK, Hayden MR, Murphy TH, Raymond LA (2010) Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice. Neuron 65:178\u2013190","journal-title":"Neuron"},{"key":"14_CR130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(01)02098-5","volume":"310","author":"I Mizuta","year":"2001","unstructured":"Mizuta I, Ohta M, Ohta K, Nishimura M, Mizuta E, Kuno S (2001) Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neurosci Lett 310:117\u2013120","journal-title":"Neurosci Lett"},{"key":"14_CR131","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.10079","volume":"51","author":"Y Momose","year":"2002","unstructured":"Momose Y, Murata M, Kobayashi K, Tachikawa M, Nakabayashi Y, Kanazawa I, Toda T (2002) Association studies of multiple candidate genes for Parkinson\u2019s disease using single nucleotide polymorphisms. Ann Neurol 51:133\u2013136","journal-title":"Ann Neurol"},{"key":"14_CR243","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","volume":"33","author":"AJ Morton","year":"2009","unstructured":"Morton AJ, Glynn D, Leavens W, Zheng Z, Faull RL, Skepper JN, Wight JM (2009) Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice. Neurobiol Dis 33:331\u2013341","journal-title":"Neurobiol Dis"},{"key":"14_CR132","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1527-3458.2008.00040.x","volume":"14","author":"JP Mostert","year":"2008","unstructured":"Mostert JP, Koch MW, Heerings M, Heersema DJ, De Keyser J (2008) Therapeutic potential of fluoxetine in neurological disorders. CNS Neurosci Ther 14:153\u2013164","journal-title":"CNS Neurosci Ther"},{"key":"14_CR133","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/342288","volume":"71","author":"M Neves-Pereira","year":"2002","unstructured":"Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL (2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71:651\u2013655","journal-title":"Am J Hum Genet"},{"key":"14_CR134","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.mp.4001575","volume":"10","author":"M Neves-Pereira","year":"2005","unstructured":"Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM (2005) BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10:208\u2013212","journal-title":"Mol Psychiatry"},{"key":"14_CR135","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson VL, Dawson TM, Ross CA (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291:2423\u20132428","journal-title":"Science"},{"key":"14_CR136","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14660820050515197","volume":"1","author":"G Ochs","year":"2000","unstructured":"Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E, Traub M, Sendtner M, Toyka KV (2000) A phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:201\u2013206","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"14_CR244","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto S, Pouladi MA, Talantova M, Yao D, Xia P, Ehrnhoefer DE, Zaidi R, Clemente A, Kaul M, Graham RK, Zhang D, Vincent Chen HS, Tong G, Hayden MR, Lipton SA (2009) Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med 15:1407\u20131413","journal-title":"Nat Med"},{"key":"14_CR245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12035-011-8219-8","volume":"45","author":"SD Olson","year":"2012","unstructured":"Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA (2012) Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington\u2019s disease. Mol Neurobiol 45:87\u201398","journal-title":"Mol Neurobiol"},{"key":"14_CR137","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrg2100","volume":"8","author":"L Ooi","year":"2007","unstructured":"Ooi L, Wood IC (2007) Chromatin crosstalk in development and disease: lessons from REST. Nat Rev Genet 8:544\u2013554","journal-title":"Nat Rev Genet"},{"key":"14_CR138","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28:2783\u20132792","journal-title":"J Neurosci"},{"key":"14_CR139","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0169-409X(98)00086-6","volume":"36","author":"W Pan","year":"1999","unstructured":"Pan W, Kastin AJ (1999) Penetration of neurotrophins and cytokines across the blood\u2013brain\/blood-spinal cord barrier. Adv Drug Deliv Rev 36:291\u2013298","journal-title":"Adv Drug Deliv Rev"},{"key":"14_CR140","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","volume":"37","author":"W Pan","year":"1998","unstructured":"Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood\u2013brain barrier. Neuropharmacology 37:1553\u20131561","journal-title":"Neuropharmacology"},{"key":"14_CR141","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2006.04.013","volume":"141","author":"TY Pang","year":"2006","unstructured":"Pang TY, Stam NC, Nithianantharajah J, Howard ML, Hannan AJ (2006) Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington\u2019s disease transgenic mice. Neuroscience 141:569\u2013584","journal-title":"Neuroscience"},{"key":"14_CR142","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.coph.2006.06.001","volume":"6","author":"WM Pardridge","year":"2006","unstructured":"Pardridge WM (2006) Molecular Trojan horses for blood\u2013brain barrier drug delivery. Curr Opin Pharmacol 6:494\u2013500","journal-title":"Curr Opin Pharmacol"},{"key":"14_CR143","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.mcn.2004.11.010","volume":"28","author":"PP Pattabiraman","year":"2005","unstructured":"Pattabiraman PP, Tropea D, Chiaruttini C, Tongiorgi E, Cattaneo A, Domenici L (2005) Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo. Mol Cell Neurosci 28:556\u2013570","journal-title":"Mol Cell Neurosci"},{"key":"14_CR144","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","volume":"210","author":"Q Peng","year":"2008","unstructured":"Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA, Duan W (2008) The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington\u2019s disease mouse model. Exp Neurol 210:154\u2013163","journal-title":"Exp Neurol"},{"key":"14_CR145","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0306-4522(98)00723-4","volume":"91","author":"E Perez-Navarro","year":"1999","unstructured":"Perez-Navarro E, Alberch J, Neveu I, Arenas E (1999) Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4\/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo. Neuroscience 91:1257\u20131264","journal-title":"Neuroscience"},{"key":"14_CR146","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","volume":"75","author":"E Perez-Navarro","year":"2000","unstructured":"Perez-Navarro E, Canudas AM, Akerund P, Alberch J, Arenas E (2000) Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington\u2019s disease. J Neurochem 75:2190\u20132199","journal-title":"J Neurochem"},{"key":"14_CR147","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-4522(99)00316-4","volume":"94","author":"TM Pham","year":"1999","unstructured":"Pham TM, Ickes B, Albeck D, Soderstrom S, Granholm AC, Mohammed AH (1999a) Changes in brain nerve growth factor levels and nerve growth factor receptors in rats exposed to environmental enrichment for one year. Neuroscience 94:279\u2013286","journal-title":"Neuroscience"},{"key":"14_CR148","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0166-4328(99)00019-4","volume":"103","author":"TM Pham","year":"1999","unstructured":"Pham TM, Soderstrom S, Winblad B, Mohammed AH (1999b) Effects of environmental enrichment on cognitive function and hippocampal NGF in the non-handled rats. Behav Brain Res 103:63\u201370","journal-title":"Behav Brain Res"},{"key":"14_CR149","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-6606-2-33","volume":"2","author":"JR Pineda","year":"2009","unstructured":"Pineda JR, Pardo R, Zala D, Yu H, Humbert S, Saudou F (2009) Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington\u2019s disease. Mol Brain 2:33","journal-title":"Mol Brain"},{"key":"14_CR246","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nbd.2012.06.026","volume":"48","author":"MA Pouladi","year":"2012","unstructured":"Pouladi MA, Brillaud E, Xie Y, Conforti P, Graham RK, Ehrnhoefer DE, Franciosi S, Zhang W, Poucheret P, Compte E, Maurel JC, Zuccato C, Cattaneo E, N\u00e9ri C, Hayden MR (2012) NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease. Neurobiol Dis 48:282\u2013289","journal-title":"Neurobiol Dis"},{"key":"14_CR150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygeno.2007.05.004","volume":"90","author":"P Pruunsild","year":"2007","unstructured":"Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90:397\u2013406","journal-title":"Genomics"},{"key":"14_CR151","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1523\/JNEUROSCI.4540-10.2011","volume":"31","author":"P Pruunsild","year":"2011","unstructured":"Pruunsild P, Sepp M, Orav E, Koppel I, Timmusk T (2011) Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. J Neurosci 31:3295\u20133308","journal-title":"J Neurosci"},{"key":"14_CR152","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(95)01321-0","volume":"709","author":"SF Radka","year":"1996","unstructured":"Radka SF, Holst PA, Fritsche M, Altar CA (1996) Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 709:122\u2013301","journal-title":"Brain Res"},{"key":"14_CR153","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/1098-1063(2000)10:5<605::AID-HIPO11>3.0.CO;2-3","volume":"10","author":"C Rampon","year":"2000","unstructured":"Rampon C, Tsien JZ (2000) Genetic analysis of learning behavior-induced structural plasticity. Hippocampus 10:605\u2013609","journal-title":"Hippocampus"},{"key":"14_CR154","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1176\/jnp.8.3.338","volume":"8","author":"NG Ranen","year":"1996","unstructured":"Ranen NG, Lipsey JR, Treisman G, Ross CA (1996) Sertraline in the treatment of severe aggressiveness in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 8:338\u2013340","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"14_CR155","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1113\/expphysiol.2009.048512","volume":"94","author":"P Rasmussen","year":"2009","unstructured":"Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, Secher NH, Pedersen BK, Pilegaard H (2009) Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 94:1062\u20131069","journal-title":"Exp Physiol"},{"key":"14_CR247","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1523\/JNEUROSCI.5100-09.2010","volume":"30","author":"S Rauskolb","year":"2010","unstructured":"Rauskolb S, Zagrebelsky M, Dreznjak A, Deogracias R, Matsumoto T, Wiese S, Erne B, Sendtner M, Schaeren-Wiemers N, Korte M, Barde YA (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 30:1739\u20131749","journal-title":"J Neurosci"},{"key":"14_CR156","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85:5733\u20135737","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR157","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, Clementi E, Hackam A, Hayden MR, Li Y, Cooper JK, Ross CA, Govoni S, Vincenz C, Cattaneo E (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20:3705\u20133713","journal-title":"J Neurosci"},{"key":"14_CR158","doi-asserted-by":"crossref","first-page":"24554","DOI":"10.1074\/jbc.M609885200","volume":"282","author":"D Rigamonti","year":"2007","unstructured":"Rigamonti D, Bolognini D, Mutti C, Zuccato C, Tartari M, Sola F, Valenza M, Kazantsev AG, Cattaneo E (2007) Loss of huntingtin function complemented by small molecules acting as repressor element 1\/neuron restrictive silencer element silencer modulators. J Biol Chem 282:24554\u201324562","journal-title":"J Biol Chem"},{"key":"14_CR159","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.2174\/138161209789649303","volume":"15","author":"D Rigamonti","year":"2009","unstructured":"Rigamonti D, Mutti C, Zuccato C, Cattaneo E, Contini A (2009) Turning REST\/NRSF dysfunction in Huntington\u2019s disease into a pharmaceutical target. Curr Pharm Des 15:3958\u20133967","journal-title":"Curr Pharm Des"},{"key":"14_CR160","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"HD Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM (2008) Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity. Brain 131:1057\u20131068","journal-title":"Brain"},{"key":"14_CR161","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrn809","volume":"3","author":"F Rossi","year":"2002","unstructured":"Rossi F, Cattaneo E (2002) Opinion: neural stem cell therapy for neurological diseases: dreams and reality. Nat Rev Neurosci 3:401\u2013409","journal-title":"Nat Rev Neurosci"},{"key":"14_CR162","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nbd.2004.01.016","volume":"16","author":"JK Ryu","year":"2004","unstructured":"Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, Choi HB, Lee MC, McLarnon JG, Kim SU (2004) Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol Dis 16:68\u201377","journal-title":"Neurobiol Dis"},{"key":"14_CR248","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jnr.23010","volume":"90","author":"KM Salerno","year":"2012","unstructured":"Salerno KM, Jing X, Diges CM, Cornuet PK, Glorioso JC, Albers KM (2012) Sox11 modulates brain-derived neurotrophic factor expression in an exon promoter-specific manner. J Neurosci Res 90:1011\u20131019","journal-title":"J Neurosci Res"},{"key":"14_CR163","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/hmg\/ddm294","volume":"17","author":"S Sarkar","year":"2008","unstructured":"Sarkar S, Krishna G, Imarisio S, Saiki S, O\u2019Kane CJ, Rubinsztein DC (2008) A rational mechanism for combination treatment of Huntington\u2019s disease using lithium and rapamycin. Hum Mol Genet 17:170\u2013178","journal-title":"Hum Mol Genet"},{"key":"14_CR164","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55\u201366","journal-title":"Cell"},{"key":"14_CR165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"14_CR166","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2004.01.003","volume":"187","author":"G Schilling","year":"2004","unstructured":"Schilling G, Savonenko AV, Coonfield ML, Morton JL, Vorovich E, Gale A, Neslon C, Chan N, Eaton M, Fromholt D, Ross CA, Borchelt DR (2004) Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice. Exp Neurol 187:137\u2013149","journal-title":"Exp Neurol"},{"key":"14_CR167","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/lm.47202","volume":"9","author":"K Schmidtke","year":"2002","unstructured":"Schmidtke K, Manner H, Kaufmann R, Schmolck H (2002) Cognitive procedural learning in patients with fronto-striatal lesions. Learn Mem 9:419\u2013429","journal-title":"Learn Mem"},{"key":"14_CR168","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.npp.1300053","volume":"28","author":"S Sen","year":"2003","unstructured":"Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, Chakravarti A, Weder AB, Burmeister M (2003) A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28:397\u2013401","journal-title":"Neuropsychopharmacology"},{"key":"14_CR169","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.mp.4001463","volume":"9","author":"VV Senatorov","year":"2004","unstructured":"Senatorov VV, Ren M, Kanai H, Wei H, Chuang DM (2004) Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington\u2019s disease. Mol Psychiatry 9:371\u2013385","journal-title":"Mol Psychiatry"},{"key":"14_CR170","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s004150170071","volume":"248","author":"K Seppi","year":"2001","unstructured":"Seppi K, Mueller J, Bodner T, Brandauer E, Benke T, Weirich-Schwaiger H, Poewe W, Wenning GK (2001) Riluzole in Huntington\u2019s disease (HD): an open label study with one year follow up. J Neurol 248:866\u2013869","journal-title":"J Neurol"},{"key":"14_CR171","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0896-6273(00)81011-9","volume":"20","author":"PB Shieh","year":"1998","unstructured":"Shieh PB, Hu SC, Bobb K, Timmusk T, Ghosh A (1998) Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20:727\u2013740","journal-title":"Neuron"},{"key":"14_CR172","doi-asserted-by":"crossref","first-page":"34880","DOI":"10.1074\/jbc.M804183200","volume":"283","author":"M Shimojo","year":"2008","unstructured":"Shimojo M (2008) Huntingtin regulates RE1-silencing transcription factor\/neuron-restrictive silencer factor (REST\/NRSF) nuclear trafficking indirectly through a complex with REST\/NRSF-interacting LIM domain protein (RILP) and dynactin p150 Glued. J Biol Chem 283:34880\u201334886","journal-title":"J Biol Chem"},{"key":"14_CR173","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","volume":"106","author":"DA Simmons","year":"2009","unstructured":"Simmons DA, Rex CS, Palmer L, Pandyarajan V, Fedulov V, Gall CM, Lynch G (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington\u2019s disease knockin mice. Proc Natl Acad Sci USA 106:4906\u20134911","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR174","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","volume":"41","author":"DA Simmons","year":"2011","unstructured":"Simmons DA, Mehta RA, Lauterborn JC, Gall CM, Lynch G (2011) Brief ampakine treatments slow the progression of Huntington\u2019s disease phenotypes in R6\/2 mice. Neurobiol Dis 41:436\u2013444","journal-title":"Neurobiol Dis"},{"key":"14_CR249","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1523\/JNEUROSCI.1310-13.2013","volume":"33","author":"DA Simmons","year":"2013","unstructured":"Simmons DA, Belichenko NP, Yang T, Condon C, Monbureau M, Shamloo M, Jing D, Massa SM, Longo FM (2013) A small molecule TrkB ligand reduces motor impairment and neuropathology in R6\/2 and BACHD mouse models of Huntington\u2019s disease. J Neurosci 33:18712\u201318727","journal-title":"J Neurosci"},{"key":"14_CR175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.mp.4001058","volume":"7","author":"P Sklar","year":"2002","unstructured":"Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, Craddock N, DePaulo JR, Lander ES (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7:579\u2013593","journal-title":"Mol Psychiatry"},{"key":"14_CR176","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"14_CR177","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-4159.2010.07122.x","volume":"116","author":"C Soldati","year":"2011","unstructured":"Soldati C, Bithell A, Conforti P, Cattaneo E, Buckley NJ (2011) Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington\u2019s disease. J Neurochem 116:415\u2013425","journal-title":"J Neurochem"},{"key":"14_CR250","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jnc.12090","volume":"124","author":"C Soldati","year":"2013","unstructured":"Soldati C, Bithell A, Johnston C, Wong KY, Stanton LW, Buckley NJ (2013) Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington\u2019s disease. J Neurochem 124:418\u2013430","journal-title":"J Neurochem"},{"key":"14_CR178","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.bbmt.2010.06.006","volume":"16","author":"R Somoza","year":"2010","unstructured":"Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ (2010) Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson\u2019s disease. Biol Blood Marrow Transplant 16:1530\u20131540","journal-title":"Biol Blood Marrow Transplant"},{"key":"14_CR179","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","volume":"24","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, Hannan AJ (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism. J Neurosci 24:2270\u20132276","journal-title":"J Neurosci"},{"key":"14_CR180","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-009-1103-3","volume":"36","author":"F Squitieri","year":"2009","unstructured":"Squitieri F, Orobello S, Cannella M, Martino T, Romanelli P, Giovacchini G, Frati L, Mansi L, Ciarmiello A (2009) Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins. Eur J Nucl Med Mol Imaging 36:1113\u20131120","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR181","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, Kurokawa R, Housman DE, Jackson GR, Marsh JL, Thompson LM (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413:739\u2013743","journal-title":"Nature"},{"key":"14_CR182","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C, Beal MF, Jones L, Kooperberg C, Olson JM, Jones KR (2007) Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27:11758\u201311768","journal-title":"J Neurosci"},{"key":"14_CR183","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238","journal-title":"Trends Genet"},{"key":"14_CR184","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","volume":"279","author":"KL Sugars","year":"2004","unstructured":"Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC (2004) Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington\u2019s disease that contributes to polyglutamine pathogenesis. J Biol Chem 279:4988\u20134999","journal-title":"J Biol Chem"},{"key":"14_CR185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01376517-200106000-00005","volume":"33","author":"FR Sullivan","year":"2001","unstructured":"Sullivan FR, Bird ED, Alpay M, Cha JH (2001) Remotivation therapy and Huntington\u2019s disease. J Neurosci Nurs 33:136\u2013142","journal-title":"J Neurosci Nurs"},{"key":"14_CR186","doi-asserted-by":"crossref","first-page":"17269","DOI":"10.1074\/jbc.M909538199","volume":"275","author":"A Tabuchi","year":"2000","unstructured":"Tabuchi A, Nakaoka R, Amano K, Yukimine M, Andoh T, Kuraishi Y, Tsuda M (2000) Differential activation of brain-derived neurotrophic factor gene promoters I and III by Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate receptor Ca2+ channels. J Biol Chem 275:17269\u201317275","journal-title":"J Biol Chem"},{"key":"14_CR187","doi-asserted-by":"crossref","first-page":"35920","DOI":"10.1074\/jbc.M204784200","volume":"277","author":"A Tabuchi","year":"2002","unstructured":"Tabuchi A, Sakaya H, Kisukeda T, Fushiki H, Tsuda M (2002) Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J Biol Chem 277:35920\u201335931","journal-title":"J Biol Chem"},{"key":"14_CR188","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1046\/j.1471-4159.2000.0741913.x","volume":"74","author":"Y Takeuchi","year":"2000","unstructured":"Takeuchi Y, Yamamoto H, Miyakawa T, Miyamoto E (2000) Increase of brain-derived neurotrophic factor gene expression in NG108-15 cells by the nuclear isoforms of Ca2+\/calmodulin-dependent protein kinase II. J Neurochem 74:1913\u20131922","journal-title":"J Neurochem"},{"key":"14_CR189","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1471-4159.2002.01096.x","volume":"83","author":"Y Takeuchi","year":"2002","unstructured":"Takeuchi Y, Miyamoto E, Fukunaga K (2002) Analysis on the promoter region of exon IV brain-derived neurotrophic factor in NG108-15 cells. J Neurochem 83:67\u201379","journal-title":"J Neurochem"},{"key":"14_CR190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","volume":"20","author":"X Tao","year":"1998","unstructured":"Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20:709\u2013726","journal-title":"Neuron"},{"key":"14_CR191","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1124\/pr.58.1.7","volume":"58","author":"D Tardito","year":"2006","unstructured":"Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M (2006) Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58:115\u2013134","journal-title":"Pharmacol Rev"},{"key":"14_CR192","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","volume":"52","author":"The BSG","year":"1999","unstructured":"The BSG (1999) A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology 52:1427\u20131433","journal-title":"Neurology"},{"key":"14_CR193","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0896-6273(93)90335-O","volume":"10","author":"T Timmusk","year":"1993","unstructured":"Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M, Persson H (1993) Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10:475\u2013489","journal-title":"Neuron"},{"key":"14_CR194","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1083\/jcb.128.1.185","volume":"128","author":"T Timmusk","year":"1995","unstructured":"Timmusk T, Lendahl U, Funakoshi H, Arenas E, Persson H, Metsis M (1995) Identification of brain-derived neurotrophic factor promoter regions mediating tissue-specific, axotomy-, and neuronal activity-induced expression in transgenic mice. J Cell Biol 128:185\u2013199","journal-title":"J Cell Biol"},{"key":"14_CR195","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0021-9258(19)88378-3","volume":"274","author":"T Timmusk","year":"1999","unstructured":"Timmusk T, Palm K, Lendahl U, Metsis M (1999) Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element. J Biol Chem 274:1078\u20131084","journal-title":"J Biol Chem"},{"key":"14_CR196","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9:2799\u20132809","journal-title":"Hum Mol Genet"},{"key":"14_CR197","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, Chacko C, McMurray CT (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24:8195\u20138209","journal-title":"Mol Cell Biol"},{"key":"14_CR198","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","volume":"404","author":"A van Dellen","year":"2000","unstructured":"van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ (2000) Delaying the onset of Huntington\u2019s in mice. Nature 404:721\u2013722","journal-title":"Nature"},{"key":"14_CR199","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1440-1681.2005.04313.x","volume":"32","author":"A van Dellen","year":"2005","unstructured":"van Dellen A, Grote HE, Hannan AJ (2005) Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington\u2019s disease. Clin Exp Pharmacol Physiol 32:1007\u20131019","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"14_CR200","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","volume":"95","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Bailey CD, Rogers DA, Johnson GV, Hayden MR, Leavitt BR (2005) Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease. J Neurochem 95:210\u2013220","journal-title":"J Neurochem"},{"key":"14_CR201","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.mp.4000952","volume":"7","author":"M Ventriglia","year":"2002","unstructured":"Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA, Gennarelli M (2002) Association between the BDNF 196 A\/G polymorphism and sporadic Alzheimer\u2019s disease. Mol Psychiatry 7:136\u2013137","journal-title":"Mol Psychiatry"},{"key":"14_CR202","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/hmg\/ddi165","volume":"14","author":"SC Warby","year":"2005","unstructured":"Warby SC, Chan EY, Metzler M, Gan L, Singaraja RR, Crocker SF, Robertson HA, Hayden MR (2005) Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. Hum Mol Genet 14:1569\u20131577","journal-title":"Hum Mol Genet"},{"key":"14_CR203","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0306-4522(01)00311-6","volume":"106","author":"H Wei","year":"2001","unstructured":"Wei H, Qin ZH, Senatorov VV, Wei W, Wang Y, Qian Y, Chuang DM (2001) Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington\u2019s disease. Neuroscience 106:603\u2013612","journal-title":"Neuroscience"},{"key":"14_CR204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V, Weaver M, Gusella JF, Joyner AL, MacDonald ME (1999) Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum Mol Genet 8:115\u2013122","journal-title":"Hum Mol Genet"},{"key":"14_CR205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0361-9230(03)00141-2","volume":"61","author":"NI Wood","year":"2003","unstructured":"Wood NI, Morton AJ (2003) Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington\u2019s disease mutation. Brain Res Bull 61:375\u2013383","journal-title":"Brain Res Bull"},{"key":"14_CR206","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1074\/jbc.M109.073197","volume":"285","author":"LL Wu","year":"2010","unstructured":"Wu LL, Fan Y, Li S, Li XJ, Zhou XF (2010) Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem 285:5614\u20135623","journal-title":"J Biol Chem"},{"key":"14_CR207","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","volume":"30","author":"Y Xie","year":"2010","unstructured":"Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice. J Neurosci 30:14708\u201314718","journal-title":"J Neurosci"},{"key":"14_CR208","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1365","volume":"12","author":"RJ Yanez-Munoz","year":"2006","unstructured":"Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ, Buch P, MacLaren RE, Anderson PN, Barker SE, Duran Y, Bartholomae C, von Kalle C, Heckenlively JR, Kinnon C, Ali RR, Thrasher AJ (2006) Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12:348\u2013353","journal-title":"Nat Med"},{"key":"14_CR209","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/7449","volume":"5","author":"D Young","year":"1999","unstructured":"Young D, Lawlor PA, Leone P, Dragunow M, During MJ (1999) Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 5:448\u2013453","journal-title":"Nat Med"},{"key":"14_CR210","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/(SICI)1097-4547(19990915)57:6<830::AID-JNR8>3.0.CO;2-2","volume":"57","author":"ZF Yu","year":"1999","unstructured":"Yu ZF, Mattson MP (1999) Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J Neurosci Res 57:830\u2013839","journal-title":"J Neurosci Res"},{"key":"14_CR211","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","volume":"11","author":"ZX Yu","year":"2002","unstructured":"Yu ZX, Li SH, Nguyen HP, Li XJ (2002) Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum Mol Genet 11:905\u2013914","journal-title":"Hum Mol Genet"},{"key":"14_CR212","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1002\/j.1460-2075.1990.tb07564.x","volume":"9","author":"F Zafra","year":"1990","unstructured":"Zafra F, Hengerer B, Leibrock J, Thoenen H, Lindholm D (1990) Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J 9:3545\u20133550","journal-title":"EMBO J"},{"key":"14_CR213","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jnen\/64.1.58","volume":"64","author":"GM Zainelli","year":"2005","unstructured":"Zainelli GM, Dudek NL, Ross CA, Kim SY, Muma NA (2005) Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. J Neuropathol Exp Neurol 64:58\u201365","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR214","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hipo.20658","volume":"20","author":"MS Zajac","year":"2010","unstructured":"Zajac MS, Pang TY, Wong N, Weinrich B, Leang LS, Craig JM, Saffery R, Hannan AJ (2010) Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington\u2019s disease mice. Hippocampus 20:621\u2013636","journal-title":"Hippocampus"},{"key":"14_CR215","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/hmg\/ddn281","volume":"17","author":"D Zala","year":"2008","unstructured":"Zala D, Colin E, Rangone H, Liot G, Humbert S, Saudou F (2008) Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet 17:3837\u20133846","journal-title":"Hum Mol Genet"},{"key":"14_CR216","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1471-4159.2003.01980.x","volume":"87","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Li M, Drozda M, Chen M, Ren S, Mejia Sanchez RO, Leavitt BR, Cattaneo E, Ferrante RJ, Hayden MR, Friedlander RM (2003) Depletion of wild-type huntingtin in mouse models of neurologic diseases. J Neurochem 87:101\u2013106","journal-title":"J Neurochem"},{"key":"14_CR251","first-page":"533","volume":"61","author":"JA Zoladz","year":"2010","unstructured":"Zoladz JA, Pilc A (2010) The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies. J Physiol Pharmacol 61:533\u2013541","journal-title":"J Physiol Pharmacol"},{"key":"14_CR217","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81:294\u2013330","journal-title":"Prog Neurobiol"},{"key":"14_CR218","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","volume":"5","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311\u2013322","journal-title":"Nat Rev Neurol"},{"key":"14_CR219","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293:493\u2013498","journal-title":"Science"},{"key":"14_CR220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E (2003) Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35:76\u201383","journal-title":"Nat Genet"},{"key":"14_CR221","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","volume":"52","author":"C Zuccato","year":"2005","unstructured":"Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, Valenza M, Cattaneo E (2005) Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery. Pharmacol Res 52:133\u2013139","journal-title":"Pharmacol Res"},{"key":"14_CR222","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","volume":"27","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Belyaev N, Conforti P, Ooi L, Tartari M, Papadimou E, MacDonald M, Fossale E, Zeitlin S, Buckley N, Cattaneo E (2007) Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington\u2019s disease. J Neurosci 27:6972\u20136983","journal-title":"J Neurosci"},{"key":"14_CR223","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","volume":"18","author":"C Zuccato","year":"2008","unstructured":"Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E (2008) Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease. Brain Pathol 18:225\u2013238","journal-title":"Brain Pathol"},{"key":"14_CR224","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"},{"issue":"8","key":"14_CR252","doi-asserted-by":"crossref","first-page":"e22966","DOI":"10.1371\/journal.pone.0022966","volume":"6","author":"C Zuccato","year":"2011","unstructured":"Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-L\u00e8vi AC, Tabrizi SJ, Di Donato S, Cattaneo E (2011) Brain-derived neurotrophic factor in patients with Huntington\u2019s disease. PLoS One 6(8):e22966","journal-title":"PLoS One"}],"container-title":["Handbook of Experimental Pharmacology","Neurotrophic Factors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-45106-5_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T10:06:29Z","timestamp":1716631589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-45106-5_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783642451058","9783642451065"],"references-count":253,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-45106-5_14","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"30 January 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}